Improving Efficiencies in Oncology Biomarker Testing

David L. Rimm, MD, PhD; Roy S. Herbst, MD, PhD

Drs. Roy Herbst and David Rimm discuss ways in which the time required to complete biomarker testing can be reduced, from obtaining and processing tissues, performing the testing, evaluating results, and reporting results to the cancer care team.

Related Videos

July 25, 2018

New Clinical Trial Data Presented at ASCO 2018: How Will it Change How you Practice?

Dr David Spigel discusses the 2 major themes highlighted at ASCO 2018: the use of cancer biomarkers to achieve precision therapy, and fine tuning treatment of patients with immunotherapy with respect to who to treat, how to treat, and how to predict clinical outcomes.

September 20, 2013

Cost, Value and Access of Personalized Medicine

Linda Bosserman provides an overview of the nuances of personalized medicine as it relates to cost, value and access